Litigation Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-11-21 |
| Court | District Court, D. Delaware | Date Terminated | 2019-05-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | ONYX THERAPEUTICS, INC. | ||
| Patents | 7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297; 9,173,857 | ||
| Attorneys | Mary I. Akhimien | ||
| Firms | Connolly Gallagher LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-03-20 | and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 filed…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | ||
| 2017-11-21 | 1 | 11. United States Patent No. 7,232,818 (the “’818 Patent”), entitled “Compounds For Enzyme Inhibition…Product prior to the expiration of U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 7,737,112; 8,129,346;… COUNT II: INFRINGEMENT OF U.S. PATENT NO. 7,232,818 47. Plaintiff hereby realleges… THE PATENTS-IN-SUIT 10. United States Patent No. 7,417,042 (the “’042 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title | External link to document | |
| 2018-03-16 | 15 | warrants that it owns United States Patent No. 7,232,818 (“the ’818 patent”), titled “Compounds for enzyme… and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 by …NOT TO SUE REGARDING U.S. PATENT NOS. 7,232,818, 7,491,704, 8,129,346, AND 8,207,297 …warrants that it owns United States Patent No. 7,491,704 (“the ’704 patent”), titled “Compounds for enzyme…warrants that it owns United States Patent No. 8,129,346 (“the ’346 patent”), titled “Compounds for enzyme | External link to document | |
| 2019-05-08 | 24 | Order | enjoined from infringing United States Patent Numbers 7,417,042, 7,737, 112, and 8,207,125, on its own…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2017-11-21 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,173,857 B2; 7,232,818 B2; 7,491,704…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
